Anticoagulation, Thombin Generation and Factor XI inhibition in ACS and Atrial Fibrillation with Dr C. Michael Gibson
06/25/23 • 30 min
We would love to hear your thoughts on the episodes!
Dr. Thomas Nero discusses current therapy with Factor X inhibitors, the new research with Factor XI inhibition and specifically the enrolling Milvexian clinical trials with Dr. C Micahel Gibson. In addition they discuss, the addition of these medications along wiht anti-platelet therapy, Lp(a) and other interesting current and future research in cardiovascular disease.
We would love to hear your thoughts on the episodes!
Dr. Thomas Nero discusses current therapy with Factor X inhibitors, the new research with Factor XI inhibition and specifically the enrolling Milvexian clinical trials with Dr. C Micahel Gibson. In addition they discuss, the addition of these medications along wiht anti-platelet therapy, Lp(a) and other interesting current and future research in cardiovascular disease.
Previous Episode
Diabetes and Cardiovascular Disease, SGLT2 inhibitors and GLP1 receptor agonists with Dr. Peter Toth
We would love to hear your thoughts on the episodes!
Dr. Thomas Nero speaks with Dr Peter Toth about the dramatic change occuring in diabtetes management and its effect on cardiovascular disease. Starting with the biochemestry of diabetes and its effects at the cellular level, the discussion goes on to speak about the role SGLT2 inhibitors and GLP1 receptor agonists play in DM management as well as the future of diabetes care. (If you want to skip the excelllent, but quite deep dive into biochemistry, jump to 11:22 - but honestly Dr. Toth's description is breathtaking)
Next Episode
Dr Elizabeth Ofili and The African American Heart Study
We would love to hear your thoughts on the episodes!
Dr. Elizabeth Ofili discusses the African American Heart Study with Dr. Thomas Nero. They also discuss her work at the NIH and the African American Heart Failure Trial and the role of community based pragmatic clinical trials.
Future Pulse Cardiology - Anticoagulation, Thombin Generation and Factor XI inhibition in ACS and Atrial Fibrillation with Dr C. Michael Gibson
Transcript
[00:00:00] Dr. Thomas Nero: Good afternoon and welcome to Future Pulse. I'm Dr. Thomas Nero today we have the pleasure of discussing Factor XIa inhibitors with Dr. Michael Gibson. Dr. Gibson is an interventional cardiologist, a cardiovascular research and educator. He's the CEO of the Baim Research Institute at Harvard Medical School.
He has offered thousands and thousands of papers on clinical trials in interventional cardiology, preventive cardiology, public health, an
If you like this episode you’ll love
Episode Comments
Generate a badge
Get a badge for your website that links back to this episode
<a href="https://goodpods.com/podcasts/future-pulse-cardiology-277889/anticoagulation-thombin-generation-and-factor-xi-inhibition-in-acs-and-34302553"> <img src="https://storage.googleapis.com/goodpods-images-bucket/badges/generic-badge-1.svg" alt="listen to anticoagulation, thombin generation and factor xi inhibition in acs and atrial fibrillation with dr c. michael gibson on goodpods" style="width: 225px" /> </a>
Copy